Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials. (2019)
Attributed to:
Renewal of the Network of Hubs for Trials Methodology Research.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/jpm9030042
PubMed Identifier: 31480618
Publication URI: http://europepmc.org/abstract/MED/31480618
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal of personalized medicine
Issue: 3
ISSN: 2075-4426